- Home
- BPMC vs TLX Comparison
BPMC vs TLX Comparison
Compare BPMC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- TLX
- Stock Information
- Founded
- BPMC 2008
- TLX 2015
- Country
- BPMC United States
- TLX Australia
- Employees
- BPMC N/A
- TLX N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- BPMC Health Care
- TLX Health Care
- Exchange
- BPMC Nasdaq
- TLX Nasdaq
- Market Cap
- BPMC 5.9B
- TLX 5.0B
- IPO Year
- BPMC 2015
- TLX N/A
- Fundamental
- Price
- BPMC $90.14
- TLX $15.82
- Analyst Decision
- BPMC Buy
- TLX Strong Buy
- Analyst Count
- BPMC 20
- TLX 1
- Target Price
- BPMC $120.79
- TLX $21.00
- AVG Volume (30 Days)
- BPMC 667.8K
- TLX 17.7K
- Earning Date
- BPMC 02-13-2025
- TLX 01-01-0001
- Dividend Yield
- BPMC N/A
- TLX N/A
- EPS Growth
- BPMC N/A
- TLX N/A
- EPS
- BPMC N/A
- TLX 0.10
- Revenue
- BPMC $434,415,000.00
- TLX $430,795,970.00
- Revenue This Year
- BPMC $108.09
- TLX N/A
- Revenue Next Year
- BPMC $39.34
- TLX N/A
- P/E Ratio
- BPMC N/A
- TLX $157.79
- Revenue Growth
- BPMC 100.93
- TLX 80.92
- 52 Week Low
- BPMC $72.24
- TLX $14.44
- 52 Week High
- BPMC $121.90
- TLX $19.99
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- TLX N/A
- Support Level
- BPMC $86.02
- TLX N/A
- Resistance Level
- BPMC $98.41
- TLX N/A
- Average True Range (ATR)
- BPMC 3.28
- TLX 0.00
- MACD
- BPMC -0.76
- TLX 0.00
- Stochastic Oscillator
- BPMC 33.04
- TLX 0.00
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.